S&P 500   3,337.95 (-0.41%)
DOW   27,448.89 (-0.49%)
QQQ   276.40 (-0.29%)
AAPL   114.03 (-0.81%)
MSFT   207.41 (-0.97%)
FB   258.96 (+0.83%)
GOOGL   1,457.28 (-0.09%)
AMZN   3,162.38 (-0.37%)
TSLA   425.97 (+1.13%)
NVDA   534.06 (+2.43%)
BABA   277.06 (+0.38%)
CGC   14.49 (+1.97%)
GE   6.07 (-2.10%)
MU   50.89 (+2.35%)
AMD   82.23 (+3.46%)
T   28.23 (-0.53%)
F   6.60 (-1.35%)
ACB   4.84 (+1.26%)
GILD   62.09 (-1.21%)
NFLX   493.95 (+0.67%)
DIS   124.13 (-1.48%)
BA   162.90 (-1.91%)
BAC   23.76 (-1.37%)
S&P 500   3,337.95 (-0.41%)
DOW   27,448.89 (-0.49%)
QQQ   276.40 (-0.29%)
AAPL   114.03 (-0.81%)
MSFT   207.41 (-0.97%)
FB   258.96 (+0.83%)
GOOGL   1,457.28 (-0.09%)
AMZN   3,162.38 (-0.37%)
TSLA   425.97 (+1.13%)
NVDA   534.06 (+2.43%)
BABA   277.06 (+0.38%)
CGC   14.49 (+1.97%)
GE   6.07 (-2.10%)
MU   50.89 (+2.35%)
AMD   82.23 (+3.46%)
T   28.23 (-0.53%)
F   6.60 (-1.35%)
ACB   4.84 (+1.26%)
GILD   62.09 (-1.21%)
NFLX   493.95 (+0.67%)
DIS   124.13 (-1.48%)
BA   162.90 (-1.91%)
BAC   23.76 (-1.37%)
S&P 500   3,337.95 (-0.41%)
DOW   27,448.89 (-0.49%)
QQQ   276.40 (-0.29%)
AAPL   114.03 (-0.81%)
MSFT   207.41 (-0.97%)
FB   258.96 (+0.83%)
GOOGL   1,457.28 (-0.09%)
AMZN   3,162.38 (-0.37%)
TSLA   425.97 (+1.13%)
NVDA   534.06 (+2.43%)
BABA   277.06 (+0.38%)
CGC   14.49 (+1.97%)
GE   6.07 (-2.10%)
MU   50.89 (+2.35%)
AMD   82.23 (+3.46%)
T   28.23 (-0.53%)
F   6.60 (-1.35%)
ACB   4.84 (+1.26%)
GILD   62.09 (-1.21%)
NFLX   493.95 (+0.67%)
DIS   124.13 (-1.48%)
BA   162.90 (-1.91%)
BAC   23.76 (-1.37%)
S&P 500   3,337.95 (-0.41%)
DOW   27,448.89 (-0.49%)
QQQ   276.40 (-0.29%)
AAPL   114.03 (-0.81%)
MSFT   207.41 (-0.97%)
FB   258.96 (+0.83%)
GOOGL   1,457.28 (-0.09%)
AMZN   3,162.38 (-0.37%)
TSLA   425.97 (+1.13%)
NVDA   534.06 (+2.43%)
BABA   277.06 (+0.38%)
CGC   14.49 (+1.97%)
GE   6.07 (-2.10%)
MU   50.89 (+2.35%)
AMD   82.23 (+3.46%)
T   28.23 (-0.53%)
F   6.60 (-1.35%)
ACB   4.84 (+1.26%)
GILD   62.09 (-1.21%)
NFLX   493.95 (+0.67%)
DIS   124.13 (-1.48%)
BA   162.90 (-1.91%)
BAC   23.76 (-1.37%)
Log in
ASX:VHT

Volpara Health Tech Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range
A$1.33
MA: A$1.33▼
A$1.33
52-Week Range N/A
Volume434,964 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Volpara Health Technologies Limited provides breast imaging analytics and analysis products for the early detection of breast cancer in the medical device software industry. The company offers VolparaEnterprise software, a cloud based breast imaging analytics platform that delivers real-time quality assurance and performance monitoring solutions; and VolparaDensity software, which provides volumetric breast density measurements. It also offers VolparaDose that computes woman's personal X-ray dose based on specific breast density; VolparaPressure that computes the compression pressure applied to the breast during a mammogram; and VolparaPositioning that automatically assesses the positioning of the patient, as well as VolparaServer products. The company operates in the Asia Pacific, Europe, the Middle East, Africa, the United States, and Canada. The company was formerly known as matakina Technology Ltd. Volpara Health Technologies Limited was founded in 2009 and is based in Wellington, New Zealand.
Read More

Beat the Market (BTM) Rank™

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

0.52 out of 5 stars


Industry, Sector and Symbol

Stock Exchange ASX
Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
Current SymbolASX:VHT
Previous Symbol
CUSIPN/A
CIKN/A
Webvolparasolutions.com
PhoneN/A

Debt

Debt-to-Equity Ratio7.21
Current Ratio2.55
Quick Ratio2.45

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueA$0.08 per share
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableOptionable

Receive VHT News and Ratings via Email

Sign-up to receive the latest news and ratings for VHT and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Volpara Health Tech (ASX:VHT) Frequently Asked Questions

Who are some of Volpara Health Tech's key competitors?

Some companies that are related to Volpara Health Tech include BARD1 Life Sciences (BD1), BioMark Diagnostics (BUX), Carl Data Solutions (CRL), Cryosite (CTE), Dorsavi (DVL), EPIGENOMICS AG/S (EPGNY), Eternity Healthcare (ETAH), Genetic Technologies (GTG), Imagin Medical (IME), Imagion Biosys (IBX), Integral Diagnostics (IDX), Lifespot Health (LSH), Medical Imaging (MEDD), OBJ (OBJ) and Oncosil Medical (OSL).
View all competitors.

What other stocks do shareholders of Volpara Health Tech own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Volpara Health Tech investors own include Sabre Resources (SBR), Webjet (WEB), Western Digital (WDC), South32 (S32), Netflix (NFLX), Nearmap (NEA), Charlotte's Web (CWBHF), Aristocrat Leisure (ALL) and Auscann Group (AC8).

Who are Volpara Health Tech's key executives?

Volpara Health Tech's management team includes the following people:
  • Dr. Ralph Highnam, CEO, Chief Scientist, Exec. Director & Member of Scientific Board
  • Mr. Craig Hadfield, CFO & Joint Company Sec.
  • Mr. David Murray Ph.D., Chief Technology Officer
  • Mr. Mark Koeniguer, Chief Commercial Officer & Pres of USA
  • Mr. Julian Marshall, Chief Product Officer

What is Volpara Health Tech's stock symbol?

Volpara Health Tech trades on the ASX under the ticker symbol "VHT."

How big of a company is Volpara Health Tech?

Volpara Health Tech has a market capitalization of $0.00.

What is Volpara Health Tech's official website?

The official website for Volpara Health Tech is volparasolutions.com.

This page was last updated on 9/29/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.